These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10483170)

  • 41. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful management for spontaneous intracranial haemorrhage under critical thrombocytopenia (platelets < 1000/mm(3)) due to adolescence-onset idiopathic thrombocytopenic purpura.
    Yoneoka Y; Tokita K; Yamauchi JI; Takeda N; Ohta H; Shindo T
    Acta Neurochir (Wien); 2004 Feb; 146(2):199-201. PubMed ID: 14963758
    [No Abstract]   [Full Text] [Related]  

  • 44. Platelet dosing.
    Schlossberg HR; Herman JH
    Transfus Apher Sci; 2003 Jun; 28(3):221-6. PubMed ID: 12725947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benign lymphoproliferation syndrome, autoimmune neutropenia and thrombocytopenia in partial Di George syndrome: efficacy of rh G-CSF and prednisone.
    Martire B; Burattini MG; De Santis A; Schettini F; De Mattia D
    Acta Paediatr; 2001 Jul; 90(7):821-3. PubMed ID: 11519990
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
    Zoghlami-Rintelen C; Weltermann A; Bittermann C; Kyrle PA; Pabinger I; Lechner K; Wenzl E
    Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A normal fixed-loss component of platelet utilization accounting for short survival of transfused platelets.
    Shulman NR; Jordan JV; Falchuk S
    Ann N Y Acad Sci; 1985; 459():367-74. PubMed ID: 3868331
    [No Abstract]   [Full Text] [Related]  

  • 48. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.
    Bussel JB; Zacharoulis S; Kramer K; McFarland JG; Pauliny J; Kaplan C
    Pediatr Blood Cancer; 2005 Aug; 45(2):176-83. PubMed ID: 15828027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system.
    Christensen RD; Henry E; Wiedmeier SE; Stoddard RA; Sola-Visner MC; Lambert DK; Kiehn TI; Ainsworth S
    J Perinatol; 2006 Jun; 26(6):348-53. PubMed ID: 16642027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches.
    Afdhal NH; Esteban R
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():1-4. PubMed ID: 17958513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indications for transfusions of labile blood products].
    Wautier JL
    Transfus Clin Biol; 2005 Feb; 12(1):56-8. PubMed ID: 15814294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
    Louwes H; Vellenga E; Houwerzijl EJ; de Wolf JT
    Ann Hematol; 2001 Dec; 80(12):728-32. PubMed ID: 11797113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical analysis of 92 cases of pregnancy with idiopathic thrombocytopenic purpura].
    Wang Q; Nie LL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):729-32. PubMed ID: 15634495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Other immune thrombocytopenias.
    Liebman H
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
    de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
    BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.
    Briggs C; Hart D; Kunka S; Oguni S; Machin SJ
    Transfus Med; 2006 Apr; 16(2):101-9. PubMed ID: 16623916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison.
    Scaradavou A; Cunningham-Rundles S; Ho JL; Folman C; Doo H; Bussel JB
    Am J Hematol; 2007 May; 82(5):335-41. PubMed ID: 17154377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.